Nerve biopsy in chronic inflammatory neuropathies: In situ biomarkers

Journal of the Peripheral Nervous System

Volumn 16, Issue SUPPL. 1, 2011, Pages 24-29

  Sommer, Claudia ^a,b   Toyka, Klaus ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

biomarker; biopsy; CIDP; diagnosis; inflammation

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN;

ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DOWN REGULATION; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MICROARRAY ANALYSIS; NERVE BIOPSY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKERS; BIOPSY; DEMYELINATING DISEASES; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79959621210     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2011.00301.x     Document Type: Article

References (36)

1. AAN AIDS Task Force (1991). Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 41: 617-618.
2. Andorfer B, Kieseier BC, Mathey E, Armati P, Pollard J, Oka N, Hartung HP, (2001). Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J Neuroimmunol 116: 226-232. (Pubitemid 32588636)
3. Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D, Wu W, Uitdehaag BM, Kappos L, Polman CH, Matthews PM, Hauser SL, Gibson RA, Oksenberg JR, Barnes MR, (2009). Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 18: 2078-2090.
4. Bosboom WM, van den Berg LH, Franssen H, Giesbergen PC, Flach HZ, van Putten AM, Veldman H, Wokke JH, (2001). Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain 124: 2427-2438. (Pubitemid 33134932)
5. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV, (1975). Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50: 621-637.
6. Gurer G, Erdem S, Kocaefe C, Ozguc M, Tan E, (2004). Expression of matrix metalloproteinases in vasculitic neuropathy. Rheumatol Int 24: 255-259. (Pubitemid 39286904)
7. Hartung HP, Pollard JD, Harvey GK, Toyka KV, (1995). Immunopathogenesis and treatment of the Guillain-Barre syndrome-Part I. Muscle Nerve 18: 137-153.
8. Hu W, Janke A, Ortler S, Hartung HP, Leder C, Kieseier BC, Wiendl H, (2007). Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies. Neurology 68: 277-282. (Pubitemid 46148339)
9. Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, Nobile-Orazio E, van Doorn P, Dalakas M, Bojar M, Swan A, (2001). Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50: 195-201. (Pubitemid 32738144)
10. Jann S, Bramerio MA, Beretta S, Koch S, Defanti CA, Toyka KV, Sommer C, (2003). Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP. Neurology 61: 1607-1610. (Pubitemid 37505589)
11. Jann S, Bramerio MA, Facchetti D, Sterzi R, (2009). Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up. J Neurol Neurosurg Psychiatry 80: 70-73.
12. Joint Task Force of the EFNS and the PNS (2005). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 10: 220-228.
13. Kanda T, Numata Y, Mizusawa H, (2004). Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1. J Neurol Neurosurg Psychiatry 75: 765-769. (Pubitemid 38526691)
14. Kiefer R, Kieseier BC, Bruck W, Hartung HP, Toyka KV, (1998). Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 121: 469-479. (Pubitemid 28116344)
15. Kieseier BC, Clements JM, Pischel HB, Wells GM, Miller K, Gearing AJ, Hartung HP, (1998). Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barre syndrome. Ann Neurol 43: 427-434. (Pubitemid 28231716)
16. Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP, (2002). Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 125: 823-834. (Pubitemid 34279777)
17. Krendel DA, Parks HP, Anthony DC, St Clair MB, Graham DG, (1989). Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 12: 257-264. (Pubitemid 19099731)
18. Lee G, Xiang Z, Brannagan TH III, Chin RL, Latov N, (2010). Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies. J Neurol Sci 290: 115-122.
19. Leppert D, Hughes P, Huber S, Erne B, Grygar C, Said G, Miller KM, Steck AJ, Probst A, Fuhr P, (1999). Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology 53: 62-70. (Pubitemid 29329650)
20. Lindenlaub T, Sommer C, (2003). Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol (Berl) 105: 593-602. (Pubitemid 36798860)
21. Mawrin C, Brunn A, Rocken C, Schroder JM, (2003). Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases. Acta Neuropathol (Berl) 105: 365-372. (Pubitemid 36805577)
22. Mazzeo A, Aguennouz M, Messina C, Vita G, (2004). Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy. Arch Neurol 61: 1097-1102. (Pubitemid 38915952)
23. Meyer zu Horste G, Reiners J, Lehmann HC, Airas L, Kieseier BC, (2009). CD73 is expressed on invading T lymphocytes in the inflamed peripheral nerve. Muscle Nerve 40: 287-289.
24. Renaud S, Erne B, Fuhr P, Said G, Lacroix C, Steck AJ, Leppert D, (2003). Matrix metalloproteinases-9 and -2 in secondary vasculitic neuropathies. Acta Neuropathol (Berl) 105: 37-42. (Pubitemid 36798015)
25. Renaud S, Hays AP, Brannagan TH III, Sander HW, Edgar M, Weimer LH, Olarte MR, Dalakas MC, Xiang Z, Danon MJ, Latov N, (2005). Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 159: 203-214. (Pubitemid 40126194)
26. Ryan MM, Jones HR Jr, (2005). CMTX mimicking childhood chronic inflammatory demyelinating neuropathy with tremor. Muscle Nerve 31: 528-530. (Pubitemid 40393101)
27. Saporta MA, Katona I, Lewis RA, Masse S, Shy ME, Li J, (2009). Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A. Brain 132: 3263-3273.
28. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J, (1996). Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 19: 474-487.
29. Sommer C, Koch S, Lammens M, Gabreels-Festen A, Stoll G, Toyka KV, (2005). Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology 65: 1924-1929. (Pubitemid 43970112)
30. Tabaraud F, Lagrange E, Sindou P, Vandenberghe A, Levy N, Vallat JM, (1999). Demyelinating X-linked Charcot-Marie-Tooth disease: unusual electrophysiological findings. Muscle Nerve 22: 1442-1447. (Pubitemid 29468431)
31. Üçeyler N, Rogausch JP, Toyka KV, Sommer C, (2007). Differential expression of cytokines in painful and painless neuropathies. Neurology 69: 42-49. (Pubitemid 47025203)
32. Üçeyler N, Kafke W, Riediger N, He L, Necula G, Toyka KV, Sommer C, (2010). Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology 74: 1806-1813.
33. Vallat JM, Tabaraud F, Magy L, Torny F, Bernet-Bernady P, Macian F, Couratier P, (2003). Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve 27: 478-485. (Pubitemid 36397067)
34. Van Rhijn I, Van den Berg LH, Bosboom WM, Otten HG, Logtenberg T, (2000). Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy. Brain 123: 2020-2029.
35. Yamamoto M, Ito Y, Mitsuma N, Li M, Hattori N, Sobue G, (2001). Pathology-related differential expression regulation of NGF, GDNF, CNTF, and IL-6 mRNAs in human vasculitic neuropathy. Muscle Nerve 24: 830-833. (Pubitemid 32476532)
36. Yamamoto M, Ito Y, Mitsuma N, Li M, Hattori N, Sobue G, (2002). Parallel expression of neurotrophic factors and their receptors in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 25: 601-604. (Pubitemid 34293136)